Money
Wedbush Raises Price Target on Apogee Therapeutics (APGE)
Wedbush has increased its price target for Apogee Therapeutics, indicating positive market sentiment.
editorial-staff
1 min read
Updated 29 days ago
Summary
Summary
- Summary pending editorial review.
Key Facts
| Fact | Value |
|---|---|
| Firm | Wedbush |
| Company | Apogee Therapeutics (APGE) |
| Date | 2026-03-10 |
Sources
Key Facts
| Fact | Value |
|---|---|
| Primary source | Yahoo Finance |
| Source count | 2 |
| First published | 2026-03-10T12:04:04.000Z |
Updates
Update at 15:46 UTC on 2026-03-13
Yahoo Finance reported UBS has increased the price target for EchoStar (SATS) stock, indicating positive market sentiment.
Sources: Yahoo Finance